EXCIPIENT LIMITEDActive

Company number 11260176Private limited companyIncorporated 2018

Key figures

£34,711-54.8%
Net assets 2024/25
+157.3%
Average annual growth 2019/20–2024/25
020 k40 k60 k80 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, EXCIPIENT LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0100 k200 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand10,75388,13957,228118,90477,829
Total assets20,753107,510151,328148,020110,006
Total liabilities21,41458,62577,55873,03476,681
Net assets / total equity3950,49574,97776,83434,711
Average number of employees11111

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: EXCIPIENT LIMITED

Company

EXCIPIENT LIMITED is a private limited company registered with Companies House under company number 11260176. It was incorporated on 16 Mar 2018. Its status is active. The registered office is in Bristol (BS40). Its nature of business (SIC 2007) is public relations and communications activities (70210), management consultancy activities other than financial management (70229), advertising agencies (73110).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files abridged accounts (unaudited). Net assets were £34,711, down 54.8% on the previous year. Cash at bank and in hand was £77,829. Total assets were £110,006 and total liabilities £76,681. The company had an average of 1 employee. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 10 Mar 2027.